Open AccessS0858 Assessing the Efficacy and Safety of a Transition From Infliximab to Infliximab Biosimilar in the Management of IBD in a Safety Net Population
Author(s) -
Timothy Yoo,
Alex Zhornitskiy,
Brian M. Fung,
Jordan Epistola,
Michael W. Fleischman,
James H. Tabibian,
Linda A. Hou
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000705480.65270.c6
Subject(s) - infliximab , medicine , biosimilar , ulcerative colitis , inflammatory bowel disease , adverse effect , discontinuation , population , crohn's disease , surgery , disease , environmental health